Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Liabilities and Shareholders Equity: 2009-2024

Historic Liabilities and Shareholders Equity for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to $2.2 billion.

  • Pediatrix Medical's Liabilities and Shareholders Equity rose 589.98% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 billion, marking a year-over-year decrease of 14.79%. This contributed to the annual value of $2.2 billion for FY2024, which is 302.32% down from last year.
  • According to the latest figures from FY2024, Pediatrix Medical's Liabilities and Shareholders Equity is $2.2 billion, which was down 302.32% from $2.2 billion recorded in FY2023.
  • In the past 5 years, Pediatrix Medical's Liabilities and Shareholders Equity registered a high of $3.3 billion during FY2020, and its lowest value of $2.2 billion during FY2024.
  • Its 5-year average for Liabilities and Shareholders Equity is $2.6 billion, with a median of $2.3 billion in 2022.
  • In the last 5 years, Pediatrix Medical's Liabilities and Shareholders Equity crashed by 1924.68% in 2020 and then crashed by 302.32% in 2024.
  • Annual analysis of 5 years shows Pediatrix Medical's Liabilities and Shareholders Equity stood at $3.3 billion in 2020, then decreased by 18.68% to $2.7 billion in 2021, then dropped by 13.76% to $2.3 billion in 2022, then decreased by 5.45% to $2.2 billion in 2023, then dropped by 3.02% to $2.2 billion in 2024.
  • Its Liabilities and Shareholders Equity stands at $2.2 billion for FY2024, versus $2.2 billion for FY2023 and $2.3 billion for FY2022.